Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Steven M. Horwitz, MD, Tatyana A. Feldman, MD, Brian T. Hess, MD, Michael S. Khodadoust, MD PhD, Youn H. Kim, MD, Javier Munoz, MD MS, FACP, Manish R. Patel, MD, Tycel J. Phillips, MD, Stephen D. Smith, MD, Sonali M. Smith, MD, Ryan A. Wilcox, MD PhD, Matt R. Birrell, Janet M. Leeds, PhD, Pamela B. Conley, PhD, Glenn C. Michelson, MD, Gregory P. Coffey, PhD, John T. Curnutte, MD PhD, Paul A. Hamlin, MD

Blood (2019) 134 (Supplement_1): 466.

https://doi.org/10.1182/blood-2019-123986

Published: 2019

Journal Articles

Say hello to TUGSE!

Kyle T. Wright, Olga Pozdnyakova

Blood (2019) 134 (16): 1360.

https://doi.org/10.1182/blood.2019002505

Published: 2019

Journal Articles

The cells are ambiguous, not the message

Pierre S. Rohrlich

Blood (2018) 132 (3): 239–240.

https://doi.org/10.1182/blood-2018-05-850248

Published: 2018

Journal Articles

Aberrant T-cell antigen expression in a plasma cell neoplasm

Smita Patel, Bachir Alobeid

Blood (2018) 132 (3): 341.

https://doi.org/10.1182/blood-2018-04-843730

Published: 2018

Journal Articles

PHF6 Mutations Defines a Subgroup of Mixed Phenotype of Acute Leukemia with Aberrant T-Cell Differentiation

Wenbin Xiao, MD, Friederike Pastore, MD, Bartlomiej Getta, MD, Anne Hultquist, MD, Brian C. Shaffer, MD, Sergio A. Giralt, MD, Raajit K. Rampal, MD PhD, Maria E. Arcila, Ross L. Levine, MD, Mikhail Roshal, MDPhD

Blood (2017) 130 (Supplement 1): 1384.

https://doi.org/10.1182/blood.V130.Suppl_1.1384.1384

Published: 2017

Journal Articles

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

Paul Michael Maciocia, BSc,MBBS,MRCP, Patrycja Wawrzyniecka, MSc, Brian Philip, PhD, Ida Ricciardelli, PhD, Ayse U. Akarca, BSc, Shimobi Onuoha, PhD, David Cole, PhD, Andrew Sewell, PhD, Karl S Peggs, MD, David C. Linch, MD MRCP, MB BCh, BA, Teresa Marafioti, MD, Martin A Pule, MD PhD

Blood (2016) 128 (22): 811.

https://doi.org/10.1182/blood.V128.22.811.811

Published: 2016

Journal Articles

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Tadao Ishida, MD PhD, Hiroshi Yasui, MD PhD, Kazuya Ishiguro, MD, Yuka Aoki, MD PhD, Hiroshi Ikeda, MD PhD

Blood (2016) 128 (22): 2097.

https://doi.org/10.1182/blood.V128.22.2097.2097

Published: 2016

Journal Articles

Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4 + T cells

Xiaojun Yu, Marta Ilecka, Emmalene J. Bartlett, Viktor Schneidt, Rauf Bhat, Josef Mautner, Regina Feederle, Henri-Jacques Delecluse

Blood (2015) 125 (10): 1601–1610.

https://doi.org/10.1182/blood-2014-07-591412

Published: 2015

Includes: Supplemental data

Journal Articles

T-Cell Therapy for Multiple Myeloma Using NY-ESO-1 + T-Cell Antigen Presenting Cells (T-APC) Combined with Adoptive Cellular Transfer (ACT) to Augment Immunotherapy

Krina K. Patel, MD, Simon Olivares, Lenka V. Hurton, PhD, Helen Huls, BS, Muzaffar H. Qazilbash, Richard E. Champlin, Laurence JN Cooper, MD PhD

Blood (2014) 124 (21): 3843.

https://doi.org/10.1182/blood.V124.21.3843.3843

Published: 2014

Journal Articles

High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology

Edus H. Warren, Frederick A. Matsen, IV, Jeffrey Chou

Blood (2013) 122 (1): 19–22.

https://doi.org/10.1182/blood-2013-03-453142

Published: 2013

Includes: Multimedia, Supplemental data

Journal Articles

Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival

Girish Venkataraman, Joo Y. Song, Alexandar Tzankov, Stephan Dirnhofer, Georg Heinze, Maria Kohl, Alexandra Traverse-Glehen, Franziska C. Eberle, Jeffrey C. Hanson, Mark A. Raffeld, Stefania Pittaluga, Elaine S. Jaffe

Blood (2013) 121 (10): 1795–1804.

https://doi.org/10.1182/blood-2012-06-439455

Published: 2013

Journal Articles

Flow Cytometric Assessment of the T-Cell Receptor Vβ Repertoire Identifies Clonal T-Cell Populations with High Specificity and Sensitivity.

Wolfgang Kern, MD, Frauke Bellos, MD, Sabine Jeromin, PhD, Tamara Alpermann, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 2661.

https://doi.org/10.1182/blood.V120.21.2661.2661

Published: 2012

Journal Articles

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

Irena Frydecka, MD, PhD, Lidia Karabon, PhD, Edyta Pawlak-Adamska, PhD, Anna Tomkiewicz, MSc, Tomasz Wrobel, prof., Miroslaw Markiewicz, MD, PhD, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2011) 118 (21): 2010.

https://doi.org/10.1182/blood.V118.21.2010.2010

Published: 2011

Journal Articles

Associations of Aberrant T Cell Antigen Expression on B Cells of Diffuse Large B Cell Lymphoma Patients with Their Background and Prognosis

Yuhko Suzuki, MD, PhD, Tsutomu Yoshida, Hirokazu Kimura, Manabu Ohsaka, Koji Miyazaki, Mikio Danbara, Ryouichi Horie, Yuhichi Satoh, Masaaki Higashihara

Blood (2010) 116 (21): 5088.

https://doi.org/10.1182/blood.V116.21.5088.5088

Published: 2010

Journal Articles

Transformation of Indolent Small B-Cell Lymphoma to Histiocytic Sarcoma: Report of Two Cases with Molecular/Genetic Evidence of Clonal Relationship Between Two Morphologically and Immunophenotypically Distinctive Neoplasms.

Endi Wang, M.D., Ph.D, Charles Blake Hutchinson, M.D., Qin Huang, MD, PhD, Siby Sebastian, Catherine Rehder

Blood (2009) 114 (22): 3960.

https://doi.org/10.1182/blood.V114.22.3960.3960

Published: 2009

Journal Articles

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies

Stephan Mielke, MD, Aarthi Shenoy, MD, Vicki S. Fellowes, Katayoun Rezvani, MD, PhD, Bipin N. Savani, MD, Laura Musse, Laura Wisch, Roger Kurlander, MD, Hanh Khuu, MD, Carol Boss, A. John Barrett, MD, FRCP

Blood (2008) 112 (11): 1168.

https://doi.org/10.1182/blood.V112.11.1168.1168

Published: 2008

Journal Articles

Impaired Immune Reconstitution after HLA-Mismatched Transplantation Due to Antigen Specific T-Cell Recognition Restricted by the Disparate Haplotype

Avital L. Amir, MD, Pim L.J. Heiden, MD, J.H. Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2008) 112 (11): 4590.

https://doi.org/10.1182/blood.V112.11.4590.4590

Published: 2008

Journal Articles

Biphenotypic Gamma-Delta T-Cell Leukemia/Lymphoma with Coexpression of Pax-5 and Other B-Cell Specific Antigens.

Henry Y. Dong, MD, PhD., Patti Cohen, MD, Po-Shing Lee, MD

Blood (2004) 104 (11): 4549.

https://doi.org/10.1182/blood.V104.11.4549.4549

Published: 2004

Journal Articles

Acquired Pure Red Cell Aplasia Associated with Clonal T-Cell Receptor (TCR) Gene Rearrangements with and without Pathologic Features of T-Cell Large Granular Lymphocytic Leukemia (T-LGLL).

Grzegorz S. Nowakowski, MD, William G. Morice, MD, PhD, Ayalew Tefferi, MD, Robert E. Phyliky

Blood (2004) 104 (11): 2819.

https://doi.org/10.1182/blood.V104.11.2819.2819

Published: 2004

Journal Articles

Rosmarinic acid inhibits Ca 2+ -dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-γ1 and Itk activity

Mi-Ae Kang, Su-Young Yun, Jonghwa Won

Blood (2003) 101 (9): 3534–3542.

https://doi.org/10.1182/blood-2002-07-1992

Published: 2003

NARROW

A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Say hello to TUGSE!

The cells are ambiguous, not the message

Aberrant T-cell antigen expression in a plasma cell neoplasm

PHF6 Mutations Defines a Subgroup of Mixed Phenotype of Acute Leukemia with Aberrant T-Cell Differentiation

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4 + T cells

T-Cell Therapy for Multiple Myeloma Using NY-ESO-1 + T-Cell Antigen Presenting Cells (T-APC) Combined with Adoptive Cellular Transfer (ACT) to Augment Immunotherapy

High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology

Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival

Flow Cytometric Assessment of the T-Cell Receptor Vβ Repertoire Identifies Clonal T-Cell Populations with High Specificity and Sensitivity.

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

Associations of Aberrant T Cell Antigen Expression on B Cells of Diffuse Large B Cell Lymphoma Patients with Their Background and Prognosis

Transformation of Indolent Small B-Cell Lymphoma to Histiocytic Sarcoma: Report of Two Cases with Molecular/Genetic Evidence of Clonal Relationship Between Two Morphologically and Immunophenotypically Distinctive Neoplasms.

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies

Impaired Immune Reconstitution after HLA-Mismatched Transplantation Due to Antigen Specific T-Cell Recognition Restricted by the Disparate Haplotype

Biphenotypic Gamma-Delta T-Cell Leukemia/Lymphoma with Coexpression of Pax-5 and Other B-Cell Specific Antigens.

Acquired Pure Red Cell Aplasia Associated with Clonal T-Cell Receptor (TCR) Gene Rearrangements with and without Pathologic Features of T-Cell Large Granular Lymphocytic Leukemia (T-LGLL).

Rosmarinic acid inhibits Ca 2+ -dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-γ1 and Itk activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only